Volume 25, Number 10—October 2019
CME ACTIVITY - Synopsis
Edwardsiella tarda Bacteremia, Okayama, Japan, 2005–2016
Table 2
Patient no. | Age, y/sex | Clinical diagnosis | Underlying disease | Treatment | Treatment duration, d | Concurrent organisms (source) | Outcome |
---|---|---|---|---|---|---|---|
1 | 77/M | Focus unknown | Cerebrovascular disease | LVX | 3 | E. coli, B. fragilis (pus) | Recovered |
2 | 79/M | Liver abscess | Cardiovascular disease | CFP/SUL→IPM/CIL→PIP→MEP, CLI→MEM | 38 | Recovered | |
3 | 70/F | Cholangitis, cholecystitis | None | CFP/SUL | 8 | Recovered | |
4 | 87/M | Focus unknown | Hepatocellular carcinoma | FEP | 11 | Died at 12 d | |
5 | 62/M | Mycotic aneurysm, liver abscess, osteomyelitis | Diabetes mellitus | IPM/CIL→AMP, GEN→SAM→VCM, PNP→VCS→PZX | 30 | Died at 39 d | |
6 | 92/F | Focus unknown | Colon cancer | CRO | 30 | Died at 32 d | |
7 | 89/F | Focus unknown | Colon cancer | CRO→MEM | 16 | Recovered | |
8 | 85/F | Liver abscess, enterocolitis | Thyroid cancer | MEM, CLI→MEM→IPM/CIL | 21 | Recovered | |
9 | 88/F | Cholangitis | Cholangiocarcinoma | IPM/CIL | 7 | Died at 40 d | |
10 | 75/F | Cholecystitis | None | PZX | 3 | Klebsiella sp., E. coli (bile) | Recovered |
11 | 101/F | Cholangitis | None | CFP/SUL | 10 | Recovered | |
12 | 61/M | Enterocolitis | Cardiovascular disease | CRO→LVX | 10 | Recovered | |
13 | 58/M | Liver abscess | Gallbladder cancer、 invasion of liver | CFP/SUL→MEM→MIN→AMP, MIN | 77 | E. faecalis, E. faecium, C. freundii, Bacteroides sp. (pus) | Recovered |
14 | 84/F | Cholangitis | Cardiovascular disease, cerebrovascular disease | CRO | 6 | Recovered | |
15 | 83/F | Cholangitis | Pancreatic cancer | CFP/SUL | 1 | Recovered | |
16 | 66/M | Liver abscess | Pancreatic cancer | CFZ→LEX | 46 | Recovered | |
17 | 85/M | Enterocolitis | Cardiovascular disease | CRO→LVX | 12 | Recovered | |
18 | 64/F | Enterocolitis | Chronic liver disease, diabetes mellitus | CMZ→AMP | 13 | Recovered | |
19 | 74/F | Secondary peritonitis | Diabetes mellitus | CMZ→TZP | 27 | E. coli, K. pneumoniae, S. anginosus, F. nucleatum (ascites) | Recovered |
20 | 63/M | Necrotizing fasciitis | None | MEM, CLI | 2 | Died at 2 d | |
21 | 45/F | Liver abscess, cholangitis | Pancreatic cancer | CFP/SUL→AMP | 31 | S. anginosus (blood) | Died at 45 d |
22 | 65/M | Cholangitis, cholecystitis | Gastric cancer, gallstone | CFP/SUL→AMP | 13 | S. gallolyticus (blood) | Recovered |
23 | 81/M | Cholangitis | Gallstone, esophageal cancer | CFP/SUL→AMP | 16 | Recovered | |
24 | 64/M | Cholangitis | Cholangiocarcinoma, gallstone | CFP/SUL→AMP | 8 | Recovered | |
25 | 59/M | Focus unknown, febrile neutropenia | Peripheral T-cell lymphoma | CZO | 12 | Recovered | |
26 | 60/F | Spontaneous bacterial peritonitis, empyema | Chronic liver disease | TZP→AMP | 5 | Died at 6 d |
*AMP, ampicillin; B. fragilis, Bacteroides fragilis; CFP/SUL, cefoperazon–sulbactam; C. freundii, Citrobacter freundii; CFZ, cefazolin; CLI, clindamycin; CMZ, cefmetazole; CRO, ceftriaxone; CZO, cefozopran; E. faecalis, Enterococcus faecalis; E. faecium, Enterococcus faecium; E. coli, Escherichia coli; FEP, cefepime; F. nucleatum, Fusobacterium nucleatum; GEN, gentamycin; IPM/CIL, imipenem–cilastatin; K. pneumoniae, Klebsiella pneumoniae; LEX, cephalexin; LVX, levofloxacin; MEM, meropenem; MIN, minocycline; PNP, panipenem; PIP, piperacillin; PZX, pazufloxacin, SAM, ampicillin sulbactam; S. anginosus, Streptococcus anginosus; S. gallolyticus, Streptococcus gallolyticus; Tx, treatment; TZP, piperacillin tazobactam. Arrows indicate the order of antimicrobial drugs used. Blank cells indicate no other concurrent organisms.